Clinical trialObsNot yet recruiting
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancreatitis
Immune Repertoire Decoding Enables Dynamic Risk Stratification During Chronic Pancreatitis-to-Pancreatic Cancer Transition
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Not yet recruiting
- Study type
- Observational
- Start
- 1 August 2026
- Expected end
- 31 December 2028
- Enrollment
- 800 participants
- Sites
- 0
- Primary outcomes
- Serum or Plasma CXCL10 (IP-10) Concentration; Serum or Plasma GLYR1 Concentration; Serum or Plasma TGF-beta Concentration; Serum or Plasma Artemin Concentration; Gut Microbiota Shannon Diversity Index
- Sponsor
- Other
- Results posted
- No
- Last update
- 13 August 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try